-
Quinocetone 25%Quinocetone 25% Premix. CAS NO.: 23696-28-8. EINECS NO.: 245-832-7. MF: C12H13N3O4read more
-
BMD 10% PremixBMD 10% Premix (Bacitracin Methylene Disalicylate) - High-Efficiency Gut Health Solution Contents BMD 10% Premix Product Specifications Key Benefits of BMD 10% Application and Dosage Related Productsread more
-
Enramycin 8%Enramycin 8% Premix. CAS NO.: 11115-82-5. Specification: 8% Premix.. Characteristics: Brown or grey brown powder; special odor.read more
-
Avilamycin 10%Avilamycin 10% premix. CAS Number: 11051-71-1. Molecular formula: C61H90Cl2O32read more
-
Tylvalosin Tartrate 20%Tylvalosin Tartrate 20% Premix. Other name: Acetylisovaleryltylosin Tartrate 20% Premixread more
-
Tylvalosin Tartrate 5%Tylvalosin Tartrate 5% Premix. Other name: Acetylisovaleryltylosin Tartrate 5% Premixread more
-
Florfenicol 10%Product Name:. Antibiotics Florfenicol 2% Premix powder for poultry livestock used in pasteurella and escherichia coli.. Composition:. Each 100g contain:Florfenicol Powder 2gread more
-
Kitasamycin 10%Kitasamycin 10% Premix. [Content Specification]:100g: 10g(1000 ten thousand IU of Kitasamycin). [Presentation]:Yellow granulesread more
-
Tylosin Phosphate 10%1.Tylosin Phosphate 10% Premix is effective on Gram-positive bacterium, Gram-negative bacterium, mycoplasma and helicoids.read more
-
Nosiheptide 0.5%Nosiheptide 0.5% Premix is a kind of special sulfur-polypeptide antibiotic for animal, environmentally feed additives. Significantly promote the growth of livestock and poultry, improve the feedread more
-
Chlortetracycline 15%Chlortetracycline 15% Premix. CAS NO.: 57-62-5. Specification: 15% Premix.. Characteristics: brown or dark brown powder or granular.read more
Dalbavancin is usually given in two doses, one week apart. Each infusion will take at least 30 minutes to complete. Injecting this medicine too quickly can cause itching, tingling, rash, back...
Current Dalbavancin Restrictions: Dalbavancin is currently restricted to outpatient use only. First doses of dalbavancin will be allowed in the ED per the ABSSSI protocol. Phase 1: ED identifies...
We would like to show you a description here but the site won’t allow us....
Dalbavancin | C88H100Cl2N10O28 | CID 16134627 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological ......
Dec 10, 2018 · Patients were randomized 7:1 to dalbavancin (1500 mg IV on days 1 and 8) or standard of care (SOC) for osteomyelitis (oral or IV) per investigator judgment for 4-6 weeks....
Dalbavancin is a lipoglycopeptide with activity against Gram-positive pathogens responsible for ABSSSI, including methicillin-resistant Staphylococcus aureus (MRSA), and is FDA-approved as...
